Month: June 2020
California campgrounds, hotels, gyms, bars and museums may reopen as soon as June 12 if their home counties can prove to the state that public health safety criteria have been met, according to new guidance issued by state health officials Friday.
Yesterday, U.S. Treasury Secretary Steven Mnuchin and Small Business Administration (SBA) Administrator Jovita Carranza released a joint statement regarding the passage of the Paycheck Protection Program (PPP) Flexibility Act, which was enacted on Friday and covered in our June 3rd blog post, Senate Passes House Bill H.R. 7010 – PPP Borrowers Breathe A Great Sigh of Relief, which explains its provisions.
The estimated costs for treating COVID-19 could add up as much as $547 billion for private insurers from 2020 to 2021 depending on the rate of infection, an updated report found.
The U.S. health care system is famously resistant to government-imposed change. It took decades to create Medicare and Medicaid, mostly due to opposition from the medical-industrial complex. Then it was nearly another half-century before the passage of the Affordable Care Act.
Nearly three months since the U.S. declared a national emergency over the new coronavirus, some states are reporting a rise in new cases as they lift restrictions meant to slow the virus’s spread.
Two months after Michael McCormick lay in a San Francisco hospital bed fighting to breathe, he fought to prove he got COVID-19 on the job and deserved workers’ compensation — and won.
Michigan, Florida, Washington and other states are trying to deal with suspected fraud at a time when their unemployment benefit programs have seen a surge of demand
Gavin Newsom knew it was a political gamble when, as the newly elected mayor of San Francisco, he promised to eradicate chronic homelessness.
After nearly two months at home due to the COVID-19 pandemic, Erica Schoenradt was making plans in May to see her dentist for a checkup.
Senate Finance Committee Chairman Chuck Grassley said that he intends to push for a vote this year on a bill that would limit drug-price increases, even as pharmaceutical companies race to find treatments and vaccines for Covid-19.